A detailed history of Hemington Wealth Management transactions in Insulet Corp stock. As of the latest transaction made, Hemington Wealth Management holds 88 shares of PODD stock, worth $28,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88
Previous 73 20.55%
Holding current value
$28,578
Previous $19,000 21.05%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

BUY
$237.06 - $288.29 $3,555 - $4,324
15 Added 20.55%
88 $23,000
Q4 2024

Jan 29, 2025

BUY
$227.79 - $275.7 $1,366 - $1,654
6 Added 8.96%
73 $19,000
Q3 2024

Nov 12, 2024

BUY
$180.69 - $239.01 $12,106 - $16,013
67 New
67 $15,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $22.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.